Search results
New mechanism of immune evasion in squamous cell carcinoma offers potential for improved treatment
Medical Xpress· 3 days agoA research group has revealed the tumor-extrinsic function of master regulator transcription...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor...
Glenmark to market BeiGene’s oncology medicines in India
Pharmaceutical Technology via Yahoo Finance· 6 days agoNational Medical Products Administration, the European Medicines Agency and the US Food and Drug...
High-Stage cSCC: Outcomes Superior With Mohs vs WLE
Medscape· 4 days agoMohs surgery appears to be superior to wide local excision (WLE) in patients with high-stage cutaneous squamous cell carcinoma (cSCC) ...
Laryngeal cancer metastasis sites, symptoms, and treatment
Medical News Today· 3 days agoLaryngeal cancer may spread to cartilage, soft tissues, or lymph nodes in the neck area and to more...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and ...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 3 days agoStages 1 and 2 cSCC represent 77% of all new cSCC annually. There are no drug products approved for treatment of Stages 1 and 2 cSCC. "We are pleased to share our progress ...
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
Zacks via Yahoo Finance· 6 days agoBeigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 4 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 7 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...